Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 May;118(2):283–288. doi: 10.1111/j.1476-5381.1996.tb15400.x

Rat striatal muscarinic receptors coupled to the inhibition of adenylyl cyclase activity: potent block by the selective m4 ligand muscarinic toxin 3 (MT3).

M C Olianas 1, A Adem 1, E Karlsson 1, P Onali 1
PMCID: PMC1909614  PMID: 8735628

Abstract

1. In rat striatal membranes, muscarinic toxin 3 (MT3), a selective ligand of the cloned m4 receptor subtype, antagonized the acetylcholine (ACh) inhibition of forskolin- and dopamine D1 receptor-stimulated adenylyl cyclase activities with pA2 values of 8.09 and 8.15, respectively. 2. In radioligand binding experiments, MT3 increased the Kd but did not change the Bmax value of [3H]-N-methylscopolamine (3H]-NMS) binding to rat striatal muscarinic receptors. The toxin displaced the major portion of the [3H]-NMS binding sites with a Ki of 8.0 nM. 3. In rat myocardium, MT3 antagonized the ACh inhibition of adenylyl cyclase with a Ki value of 860 nM. 4. In rat cerebral cortical membranes prelabelled with [3H]-myo-inositol, MT3 counteracted the methacholine stimulation of [3H]-inositol phosphates formation with a Ki value of 113 nM. 5. The present study shows that MT3 is a potent antagonist of the striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity. This finding provides strong evidence for the classification of these receptors as pharmacologically equivalent to the m4 gene product (M4). On the other hand, the weaker potencies of MT3 in antagonizing the muscarinic responses in cerebral cortex and in the heart are consistent with the reported lower affinities of the toxin for the cloned m1 and m2 receptor subtypes, respectively.

Full text

PDF
283

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adem A., Asblom A., Johansson G., Mbugua P. M., Karlsson E. Toxins from the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinyl benzilate to muscarinic acetylcholine receptors. Biochim Biophys Acta. 1988 Mar 11;968(3):340–345. doi: 10.1016/0167-4889(88)90025-0. [DOI] [PubMed] [Google Scholar]
  3. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  4. Brann M. R., Buckley N. J., Bonner T. I. The striatum and cerebral cortex express different muscarinic receptor mRNAs. FEBS Lett. 1988 Mar 28;230(1-2):90–94. doi: 10.1016/0014-5793(88)80648-3. [DOI] [PubMed] [Google Scholar]
  5. Buckley N. J., Bonner T. I., Brann M. R. Localization of a family of muscarinic receptor mRNAs in rat brain. J Neurosci. 1988 Dec;8(12):4646–4652. doi: 10.1523/JNEUROSCI.08-12-04646.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Claro E., Wallace M. A., Fain J. N. Concerted CMP-dependent [3H]inositol labeling of phosphoinositides and agonist activation of phospholipase C in rat brain cortical membranes. J Neurochem. 1992 Jun;58(6):2155–2161. doi: 10.1111/j.1471-4159.1992.tb10958.x. [DOI] [PubMed] [Google Scholar]
  7. Ehlert F. J., Delen F. M., Yun S. H., Friedman D. J., Self D. W. Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart. J Pharmacol Exp Ther. 1989 Nov;251(2):660–671. [PubMed] [Google Scholar]
  8. Forray C., el-Fakahany E. E. On the involvement of multiple muscarinic receptor subtypes in the activation of phosphoinositide metabolism in rat cerebral cortex. Mol Pharmacol. 1990 Jun;37(6):893–902. [PubMed] [Google Scholar]
  9. Gil D. W., Wolfe B. B. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase. J Pharmacol Exp Ther. 1985 Mar;232(3):608–616. [PubMed] [Google Scholar]
  10. Hersch S. M., Gutekunst C. A., Rees H. D., Heilman C. J., Levey A. I. Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies. J Neurosci. 1994 May;14(5 Pt 2):3351–3363. doi: 10.1523/JNEUROSCI.14-05-03351.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Jerusalinsky D., Harvey A. L. Toxins from mamba venoms: small proteins with selectivities for different subtypes of muscarinic acetylcholine receptors. Trends Pharmacol Sci. 1994 Nov;15(11):424–430. doi: 10.1016/0165-6147(94)90092-2. [DOI] [PubMed] [Google Scholar]
  12. Jolkkonen M., van Giersbergen P. L., Hellman U., Wernstedt C., Karlsson E. A toxin from the green mamba Dendroaspis angusticeps: amino acid sequence and selectivity for muscarinic m4 receptors. FEBS Lett. 1994 Sep 19;352(1):91–94. doi: 10.1016/0014-5793(94)00933-3. [DOI] [PubMed] [Google Scholar]
  13. Karlsson E., Jolkkonen M., Satyapan N., Adem A., Kumlin E., Hellman U., Wernstedt C. Protein toxins that bind to muscarinic acetylcholine receptors. Ann N Y Acad Sci. 1994 Mar 9;710:153–161. doi: 10.1111/j.1749-6632.1994.tb26623.x. [DOI] [PubMed] [Google Scholar]
  14. Keen M., Nahorski S. R. Muscarinic acetylcholine receptors linked to the inhibition of adenylate cyclase activity in membranes from the rat striatum and myocardium can be distinguished on the basis of agonist efficacy. Mol Pharmacol. 1988 Dec;34(6):769–778. [PubMed] [Google Scholar]
  15. Lazareno S., Buckley N. J., Roberts F. F. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells. Mol Pharmacol. 1990 Dec;38(6):805–815. [PubMed] [Google Scholar]
  16. Max S. I., Liang J. S., Potter L. T. Purification and properties of m1-toxin, a specific antagonist of m1 muscarinic receptors. J Neurosci. 1993 Oct;13(10):4293–4300. doi: 10.1523/JNEUROSCI.13-10-04293.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Max S. I., Liang J. S., Valentine H. H., Potter L. T. Use of m1-toxin as a selective antagonist of m1 muscarinic receptors. J Pharmacol Exp Ther. 1993 Oct;267(1):480–485. [PubMed] [Google Scholar]
  18. McKinney M., Anderson D., Forray C., el-Fakahany E. E. Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor. J Pharmacol Exp Ther. 1989 Aug;250(2):565–572. [PubMed] [Google Scholar]
  19. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  20. Olianas M. C., Onali P. Muscarinic stimulation of adenylate cyclase activity of rat olfactory bulb. II. Characterization of the antagonist sensitivity and comparison with muscarinic inhibitions of the enzyme in striatum and heart. J Pharmacol Exp Ther. 1991 Nov;259(2):680–686. [PubMed] [Google Scholar]
  21. Olianas M. C., Onali P., Neff N. H., Costa E. Adenylate cyclase activity of synaptic membranes from rat striatum. Inhibition by muscarinic receptor agonists. Mol Pharmacol. 1983 Mar;23(2):393–398. [PubMed] [Google Scholar]
  22. Olianas M. C., Onali P., Neff N. H., Costa E. Muscarinic receptors modulate dopamine-activated adenylate cyclase of rat striatum. J Neurochem. 1983 Nov;41(5):1364–1369. doi: 10.1111/j.1471-4159.1983.tb00834.x. [DOI] [PubMed] [Google Scholar]
  23. Onali P., Aasen A. J., Olianas M. C. Antagonism by (R)- and (S)-trihexyphenidyl of muscarinic stimulation of adenylyl cyclase in rat olfactory bulb and inhibition in striatum and heart. Br J Pharmacol. 1994 Nov;113(3):775–780. doi: 10.1111/j.1476-5381.1994.tb17060.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Peralta E. G., Ashkenazi A., Winslow J. W., Ramachandran J., Capon D. J. Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature. 1988 Aug 4;334(6181):434–437. doi: 10.1038/334434a0. [DOI] [PubMed] [Google Scholar]
  25. Salomon Y., Londos C., Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem. 1974 Apr;58(2):541–548. doi: 10.1016/0003-2697(74)90222-x. [DOI] [PubMed] [Google Scholar]
  26. Waelbroeck M., Tastenoy M., Camus J., Christophe J. Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain. Mol Pharmacol. 1990 Aug;38(2):267–273. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES